| Hans-Günter Meyer-Thompson | Hepatitiden
Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma.
Impact of direct-acting antiviral therapy for hepatitis C-related hepatocellular carcinoma.
Lin WC, Lin YS, Chang CW, et al.
PLoS One. 2020;15(5):e0233212. Published 2020 May 22. doi:10.1371/journal.pone.0233212
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0233212